Bicycle Therapeutics (BCYC) Revenue (2018 - 2026)

Bicycle Therapeutics (BCYC) has 9 years of Revenue data on file, last reported at $629000.0 in Q2 2026.

• Quarterly Revenue fell 78.46% year-over-year to $629000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $61.2 million (up 217.44% YoY) and the FY2025 annual result came in at $72.6 million, up 105.77% from the prior year.
• Revenue fell to $629000.0 in Q2 2026, from $887000.0 in the prior quarter.
• In the past five years, Revenue ranged from a high of $48.0 million in Q4 2025 to a low of $629000.0 in Q2 2026.
• A 5-year average of $8.4 million and a median of $5.3 million in 2023 frame the typical range for Revenue.
• Annual changes were most pronounced in 2025 — Revenue jumped 1193.28% — and 2026, when it sank 91.11%.
• Tracing BCYC's Revenue over 5 years: stood at $8.4 million in 2022, then plunged by 36.54% to $5.3 million in 2023, then plunged by 30.44% to $3.7 million in 2024, then jumped by 1193.28% to $48.0 million in 2025, then slumped by 98.69% to $629000.0 in 2026.
• The last three Revenue figures came in at $629000.0 (Q2 2026), $887000.0 (Q1 2026), and $48.0 million (Q4 2025), per Business Quant data.